The Stop TB Partnership Working Group on New Drugs (WGND)’ Annual Meeting will take place virtually on 3 November 2022.

Episode 5 of the podcast series, The Dose, by the Stop TB Partnership's Working Group on New TB Drugs (WGND) is now available online. Shobha Shukla speaks with two experts on highly drug-resistant TB, Dr. Francesca Conradie and Dr. Gustavo Velásquez, on the results from ZeNix, a Phase 3 clinical trial exploring potential optimization of a regimen for treating patients with highly drug-resistant TB.

Episode 4 of the podcast series, The Dose, by the Stop TB Partnership's Working Group on New TB Drugs (WGND) is now available online. Shobha Shukla speaks with TB regimen development experts Dr. Debra Hanna and Dr. Robert Bates on the topic of the PAN-TB collaboration and novel regimen development.

The Stop TB Partnership's Working Group on New TB Drugs (WGND) has released the latest episode of ‘The Dose’ podcast. It focuses on the first-ever UN High-Level Meeting on TB (UN HLM) held in September 2018 and the commitments made there to fight TB.

To support community engagement, the Stop TB Partnership's Working Group on New TB Drugs (WGND) will provide a one-year grant to support small scale community initiatives that will enhance and increase community engagement and input into TB drug research & development (R&D).